Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia

Schizophrenia is considered a debilitating neurodevelopmental psychiatric disorder and its pharmacotherapy remains problematic without recent major advances. The development of interventions able to prevent the emergence of schizophrenia would therefore represent an enormous progress. Here, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Peres, Fernanda F., Diana, Mariana C., Levin, Raquel, Suiama, Mayra A., Almeida, Valéria, Vendramini, Ana M., Santos, Camila M., Zuardi, Antônio W., Hallak, Jaime E. C., Crippa, José A., Abílio, Vanessa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113576/
https://www.ncbi.nlm.nih.gov/pubmed/30186164
http://dx.doi.org/10.3389/fphar.2018.00901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113576/
https://www.ncbi.nlm.nih.gov/pubmed/30186164
http://dx.doi.org/10.3389/fphar.2018.00901

Ejemplares similares